Skip to main content
Log in

Dextromethorphan Mitigates Phantom Pain in Cancer Amputees

  • Original Articles
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background: Hyperexcitability of N-methyl-d-aspartate (NMDA) receptors may play a role in the persistence of phantom pain. Dextromethorphan (DM) blocks NMDA receptors.

Methods: Eight cancer and two noncancer amputees with established, disabling phantom pain received oral DM 60 or 90 mg twice daily (BID) in a three-period double-blind crossover placebo-controlled trial. This followed an open-phase trial in which either dose was given three times daily if pain relief during the double-blind phase was <50% of pretreatment intensity. Patients then underwent a 3-month phase of treatment with the best regimen and a subsequent 1-month posttreatment follow-up.

Results: All patients reported a >50% decrease in pain intensity, better mood, and lower sedation in each treatment phase. Four individuals reported this level of pain relief with the 60-mg and one with the 90-mg BID regimen during the double-blind phase, whereas two amputees benefited from the 60-mg and three from the 90-mg thrice-daily regimen in the open-phase trial. One reported exacerbation of pain with the 90-mg BID regimen, and three reported pain rebound at the 1-month posttreatment follow-up phase. Three patients stopped all previous analgesic use during the study.

Conclusions: Persistent phantom pain probably involves NMDA receptor hyperexcitability because DM 120 to 270 mg/day mitigated the pain satisfactorily.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Devor M. The pathophysiology of damaged peripheral nerves. In: Wall PD, Melzack R, eds. Textbook of Pain. 3rd ed. London: Churchill Livingston, 1994: 79–100.

    Google Scholar 

  2. Melzack R. Phantom limb pain. Anesthesiology 1971; 35: 409–19.

    PubMed  CAS  Google Scholar 

  3. Bach S, Noreng MF, Tjellden NU. Phantom limb pain in amputees during the first 12 months following limb amputation, after preoperative lumbar epidural blockade. Pain 1988; 33: 297–301.

    PubMed  CAS  Google Scholar 

  4. Danshaw CB. An anesthetic approach to amputation and pain syndromes. Phys Med Rehabil Clin North Am 2000; 11: 553–7.

    CAS  Google Scholar 

  5. Nikolajsen L, Jensen TS. Phantom limb pain. Curr Rev Pain 2000; 4: 166–170.

    PubMed  CAS  Google Scholar 

  6. Jensen TS, Krebs B, Nielsen J, Rasmussen P. Immediate and long-term phantom limb pain in amputees: incidence, clinical characteristics and relationship to pre-amputation pain. Pain 1985; 21: 267–78.

    PubMed  CAS  Google Scholar 

  7. Woolf CJ, Wall PD. The relative effectiveness of C primary afferent fibres of different origins in evoking a prolonged facilitation of the flexor reflex in the rat. J Neurosci 1986; 6: 1433–43.

    PubMed  CAS  Google Scholar 

  8. Ren K, Hylden JL, Williams GM, et al. The effects of a non-competitive NMDA receptor antagonist, MK801, on behavioral hyperalgesia and dorsal horn neuronal activity in rats with unilateral inflammation. Pain 1992; 50: 331–44.

    PubMed  CAS  Google Scholar 

  9. Woolf CJ, Thompson SWN. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation: implications for the treatment of post-injury pain hypersensitivity states. Pain 1991; 44: 293–9.

    Article  PubMed  CAS  Google Scholar 

  10. Eisenberg E, Pud D. Can patients with chronic neuropathic pain be cure of dextromethorphan in pain control. Pain 1998; 74: 337–9.

    PubMed  CAS  Google Scholar 

  11. Nikolajsen L, Hansen CL, Nielsen J, et al. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain 1996; 67: 69–77.

    PubMed  CAS  Google Scholar 

  12. Nikolajsen L, Gottrup H, Kristensen AG, Jensen TS. Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study. Anesth Analg 2000; 91: 960–6.

    PubMed  CAS  Google Scholar 

  13. Gottschalk A, Schroeder F, Ufer M, Oncu A, Buerkle H, Standl T. Amantadine, a N-methyl-D-aspartate receptor antagonist, does not enhance postoperative analgesia in women undergoing abdominal hysterectomy. Anesth Analg 2001; 93: 192–6.

    PubMed  CAS  Google Scholar 

  14. Weinbroum AA, Gorodezky A, Niv D, et al. Dextromethorphan attenuation of postoperative pain and primary and secondary thermal hyperalgesia. Can J Anaesth 2001; 48: 167–74.

    PubMed  CAS  Google Scholar 

  15. McQuay HJ, Carroll D, Jadad AR, et al. Dextromethorphan for the treatment of neuropathic pain: a double-blind randomized controlled crossover trial with integral n-of-1 design. Pain 1994; 59: 127–33.

    PubMed  CAS  Google Scholar 

  16. Ilkjaer S, Dirks J, Brennum M, Dahl JB. Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans. Br J Anaesth 1997; 79: 600–5.

    PubMed  CAS  Google Scholar 

  17. Angrilli A, Koster U. Psychophysiological stress responses in amputees with and without phantom limb pain. Physiol Behav 2000; 68: 699–706.

    PubMed  CAS  Google Scholar 

  18. Ben-Abraham R, Weinbroum AA. Dextromethorphan in chronic pain: a disappointing update. Isr Med Assoc J 2000; 2: 708–10.

    PubMed  CAS  Google Scholar 

  19. Mercadante S, Casuccio A, Genovese G. Ineffectiveness of dextromethorphan in cancer pain. J Pain Symptom Manage 1998; 16: 317–22.

    PubMed  CAS  Google Scholar 

  20. Nelson KA, Park KM, Robinovitz E, Tsigos C, Max MB. High dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia. Neurology 1997; 48: 1212–8.

    PubMed  CAS  Google Scholar 

  21. Kauppila T, Gronroos M, Pertovaara A. An attempt to attenuate experimental pain in humans by dextromethorphan, an NMDA receptor antagonist. Pharmacol Biochem Behav 1995; 52: 641–4.

    PubMed  CAS  Google Scholar 

  22. Tal M, Bennet G. Dextrorphan relieves neuropathic heat-evoked hyperalgesia in the rat. Neurosci Lett 1993; 151: 107–10.

    PubMed  CAS  Google Scholar 

  23. Sugimoto T, Bennett G, Kajander K. Transsynaptic degeneration in the superficial dorsal horn after sciatic nerve injury: effects of chronic constriction injury, transection, and strychnine. Pain 1990; 42: 205–13.

    PubMed  CAS  Google Scholar 

  24. Weinbroum AA. Dextromethorphan reduces immediate and late postoperative analgesic requirements and improves patients’ subjective scorings after epidural lidocaine and general anesthesia. Anesth Analg 2002; 94: 1547–52.

    PubMed  CAS  Google Scholar 

  25. Weinbroum AA, Rudick V, Paret G, Ben-Abraham R. The role of dextromethorphan in pain control. Can J Anaesth 2000; 47: 585–96.

    Article  PubMed  CAS  Google Scholar 

  26. Henderson DJ, Withington BS, Wilson JA, Morrison LM. Perioperative dextromethorphan reduces postoperative pain after hysterectomy. Anesth Analg 1999; 89: 399–402.

    PubMed  CAS  Google Scholar 

  27. Suzuki T, Kato J, Saeki S, Ogawa S, Suzuki H. Analgesic effect of dextromethorphan for postherpetic neuralgia (in Japanese). Masui 1996; 45: 629–33.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Avi A. Weinbroum MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abraham, R.B., Marouani, N. & Weinbroum, A.A. Dextromethorphan Mitigates Phantom Pain in Cancer Amputees. Ann Surg Oncol 10, 268–274 (2003). https://doi.org/10.1245/ASO.2003.08.007

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1245/ASO.2003.08.007

Key Words

Navigation